These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28885611)

  • 1. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance.
    Rosenberg AS; Brunson A; Paulus JK; Tuscano J; Wun T; Keegan THM; Jonas BA
    Blood Cancer J; 2017 Sep; 7(9):e605. PubMed ID: 28885611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy.
    Kelleher N; Gallardo D; González-Campos J; Hernández-Rivas JM; Montesinos P; Sarrá J; Gil C; Barba P; Guàrdia R; Brunet S; Bernal T; Martínez MP; Abella E; Bermúdez A; Sánchez-Delgado M; Antònia C; Gayoso J; Calbacho M; Ribera JM;
    Leuk Lymphoma; 2016; 57(1):86-91. PubMed ID: 25860236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.
    Teng CJ; Huon LK; Hu YW; Yeh CM; Chien SH; Chen SC; Liu CJ
    PLoS One; 2016; 11(4):e0152909. PubMed ID: 27035574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of subsequent malignancies in survivors of childhood leukemia.
    Perkins SM; Dewees T; Shinohara ET; Reddy MM; Frangoul H
    J Cancer Surviv; 2013 Dec; 7(4):544-50. PubMed ID: 23749687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
    Saygin C; Kishtagari A; Cassaday RD; Reizine N; Yurkiewicz I; Liedtke M; Stock W; Larson RA; Levine RL; Tallman MS; Park JH; Kerr C; Przychodzen B; Sekeres MA; Kalaycio ME; Carraway HE; Hamilton BK; Sobecks R; Gerds A; Mukherjee S; Nazha A; Maciejewski JP; Advani AS
    Blood Adv; 2019 Dec; 3(24):4228-4237. PubMed ID: 31869410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
    Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
    Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Second neoplasms after malignant diseases in childhood].
    Kaatsch P; Michaelis J
    Klin Padiatr; 1995; 207(4):158-63. PubMed ID: 7564146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
    Renard M; Suciu S; Bertrand Y; Uyttebroeck A; Ferster A; van der Werff Ten Bosch J; Mazingue F; Plouvier E; Robert A; Boutard P; Millot F; Munzer M; Mechinaud F; Lescoeur B; Baila L; Vandecruys E; Benoit Y; Philippet P;
    Pediatr Blood Cancer; 2011 Jul; 57(1):119-25. PubMed ID: 21412967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
    Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
    Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study.
    Rebora P; Czene K; Antolini L; Gambacorti Passerini C; Reilly M; Valsecchi MG
    Am J Epidemiol; 2010 Nov; 172(9):1028-33. PubMed ID: 20861143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of Second Primary Malignancies in Pediatric Acute Lymphoblastic Leukemia Survivors: A Multicenter Study by the Turkish Pediatric Hematology Society.
    Toret E; Aytac S; Guzelkucuk Z; Celkan T; Genc DB; Sezgin-Evim M; Cakmakli HF; Bahadir A; Karapinar TH; Oren H; Pekpak E; Karakurt N; Korkmaz-Unlu HE; Yarali N; Gunes AM
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e363-e367. PubMed ID: 38748607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).
    Gabriel M; Shaw BE; Brazauskas R; Chen M; Margolis DA; Sengelov H; Dahlberg A; Ahmed IA; Delgado D; Lazarus HM; Gibson B; Myers KC; Kamble RT; Abdel-Mageed A; Li CK; Flowers MED; Battiwalla M; Savani BN; Majhail N; Shaw PJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1320-1326. PubMed ID: 28411175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
    Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
    JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
    Borgmann A; Zinn C; Hartmann R; Herold R; Kaatsch P; Escherich G; Möricke A; Henze G; von Stackelberg A;
    Eur J Cancer; 2008 Jan; 44(2):257-68. PubMed ID: 17981026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.